Health and Fitness Health and Fitness
Thu, October 21, 2010
[ Thu, Oct 21st 2010 ] - Market Wire
EA bernimmt Chillingo
[ Thu, Oct 21st 2010 ] - Market Wire
USB, C, JPM, GS, BAC
[ Thu, Oct 21st 2010 ] - Market Wire
WFC,JPM,C,BAC,BA
[ Thu, Oct 21st 2010 ] - Market Wire
40 P.M. ET in Los Angeles
Wed, October 20, 2010
[ Wed, Oct 20th 2010 ] - Market Wire
EA Acquires Chillingo

Celldex Therapeutics to Present at the BioCentury NewsMakers in the Biotech Industry Conference


Published on 2010-10-20 12:45:42 - Market Wire
  Print publication without navigation


NEEDHAM, Mass.--([ BUSINESS WIRE ])--Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that Thomas Davis, M.D., Senior Vice President and Chief Medical Officer of Celldex Therapeutics, Inc., will present at the BioCentury NewsMakers in the Biotech Industry Conference onFriday, October 22nd, at 2:00 p.m. EDT in New York City.

A live webcast of the presentation will be available on the aPresentationsa page of the aInvestorsa section of Celldexa™s website at [ http://www.celldextherapeutics.com ] and will be archived for 30 days following the event.

About Celldex Therapeutics, Inc.

Celldex Therapeutics is the first antibody-based combination immunotherapy company. Celldex has a pipeline of drug candidates in development for the treatment of cancer and other difficult-to-treat diseases based on its antibody focused Precision Targeted Immunotherapy Platform. The PTI Platform is a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators used in optimal combinations to create novel disease-specific drug candidates. For more information, please visit [ http://www.celldextherapeutics.com ].